Precigen (PGEN) AI Analysis
Score
Precigen is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 64/100) in Biotechnology. Under the hood: P/E 66.5, plus revenue compounding ~11% annually over recent years. Street targets still imply ~230% upside.